Stryker, Danaher, and Gilead Sciences are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or provide healthcare products and services, such as pharmaceuticals, medical devices, biotechnology, and healthcare services. Investors may consider them for exposure to healthcare-sector growth, though their performance can be affected by regulation, clinical-trial results, and changes in healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Stryker (SYK)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
Shares of SYK stock traded down $3.11 during trading on Friday, reaching $309.28. The company's stock had a trading volume of 1,333,031 shares, compared to its average volume of 2,511,551. Stryker has a 1-year low of $267.00 and a 1-year high of $389.33. The stock's 50-day moving average price is $292.28 and its 200 day moving average price is $322.83. The company has a market capitalization of $117.74 billion, a price-to-earnings ratio of 32.94, a P/E/G ratio of 2.19 and a beta of 0.78. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.18 and a quick ratio of 1.30.
Read Our Latest Research Report on SYK
Danaher (DHR)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Danaher stock traded down $1.86 during mid-day trading on Friday, reaching $230.30. 992,830 shares of the company's stock were exchanged, compared to its average volume of 4,416,638. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. Danaher has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a market cap of $162.02 billion, a P/E ratio of 37.73, a P/E/G ratio of 2.95 and a beta of 0.76. The company has a fifty day moving average of $222.11 and a 200-day moving average of $201.53.
Read Our Latest Research Report on DHR
Gilead Sciences (GILD)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.
Shares of NASDAQ:GILD traded up $0.35 during trading on Friday, hitting $168.30. The company's stock had a trading volume of 1,187,191 shares, compared to its average volume of 6,788,583. Gilead Sciences has a fifty-two week low of $116.88 and a fifty-two week high of $176.58. The business has a 50 day moving average price of $154.76 and a two-hundred day moving average price of $141.66. The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.22 and a current ratio of 1.38. The company has a market capitalization of $208.75 billion, a PE ratio of -53.27 and a beta of 0.35.
Read Our Latest Research Report on GILD
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stryker, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stryker wasn't on the list.
While Stryker currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
